Simple Blood Test will help doctors monitor patients with biphasic and epithelioid mesothelioma The Food and Drug Administration (FDA) on January 25, 2007 approved the MESOMARK(R) Assay, the world’s first in-vitro test for mesothelioma, a rare and aggressive form of cancer caused by asbestos exposure.  MESOMARK will allow doctors to monitor patients with epithelioid and biphasic […]

Simple Blood Test will help doctors monitor patients with biphasic and epithelioid mesothelioma

The Food and Drug Administration (FDA) on January 25, 2007 approved the MESOMARK(R) Assay, the world’s first in-vitro test for Mesothelioma Information continued….

Discover The Truth About Cancer That Your Doctor Doesn’t Know And The Drug Companies Hope You Never Find Out. DETAILS HERE